miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
Introduction: The standard treatment for head and neck squamous cell carcinoma (HNSCC) is cisplatin chemoradiotherapy. One of the main treatment adverse reactions is nephrotoxicity, for which there is currently no adequate specific and sensitive biomarker. Thus, this study aimed to evaluate the use...
Main Authors: | Nadine De Godoy Torso, Julia Coelho França Quintanilha, Maria Aparecida Cursino, Eder De Carvalho Pincinato, Pía Loren, Luis A. Salazar, Carmen Silvia Passos Lima, Patricia Moriel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1275238/full |
Similar Items
-
Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin
by: Nadine de Godoy Torso, et al.
Published: (2023-06-01) -
Cisplatin Induced Nephrotoxicity
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2014-02-01) -
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Julia C. F. Quintanilha, et al.
Published: (2021-05-01) -
Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update
by: Pía Loren, et al.
Published: (2021-05-01) -
Time course of cisplatin-induced nephrotoxicity and hepatotoxicity
by: Zahra Pezeshki, et al.
Published: (2017-07-01)